FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival

ABSTRACT Background FXYD3 is a Na/K‐ATPase modulator which is upregulated in pancreatic ductal adenocarcinoma (PDAC), but its prognostic role is unknown. This study evaluated FXYD3 expression in chemo‐naive patients with surgically‐resected PDAC at a single centre (1993–2014). Method FXYD3 expressio...

Full description

Bibliographic Details
Published in:	Cancer Medicine
Main Authors:	Nathalie B. Rasko, Christopher B. Nahm, John Turchini, Rachel Teh, Helge Rasmussen, Sooin Byeon, Sumit Sahni, Jaswinder S. Samra, Anthony J. Gill, Anubhav Mittal
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Subjects:	FXYD3 MAT‐8 pancreatic cancer pancreatic ductal adenocarcinoma prognosis survival
Online Access:	https://doi.org/10.1002/cam4.70500

Similar Items

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
by: Sumit Sahni, et al.
Published: (2023-09-01)

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
by: William A. Ziaziaris, et al.
Published: (2024-12-01)

Identification of FXYD6 as the novel biomarker for glioma based on differential expression and DNA methylation
by: Weiliang Hou, et al.
Published: (2023-12-01)

Microglial SIX2 suppresses lipopolysaccharide (LPS)-induced neuroinflammation by up-regulating FXYD2 expression
by: Xia-yin Cao, et al.
Published: (2024-06-01)

FXYD5: Na+/ K+-ATPase Regulator in Health and Disease.
by: Irina eLubarski Gotliv
Published: (2016-03-01)

Identification of prognostic subtypes and the role of FXYD6 in ovarian cancer through multi-omics clustering
by: Boyi Ma, et al.
Published: (2025-03-01)

Association analysis of FXYD5 with prognosis and immunological characteristics across pan-cancer
by: Yang Bai, et al.
Published: (2024-05-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

Displacement of Native FXYD Protein From Na+/K+-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity
by: Chia-Chi Liu, et al.
Published: (2022-03-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
by: Tomonari Shimagaki, et al.
Published: (2023-11-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
by: Gitika Thakur, et al.
Published: (2021-02-01)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
by: Jannat Pervin, et al.
Published: (2023-10-01)

Utility of Contrast-Enhanced Computed Tomography for Differentiating Pancreatic Ductal Adenocarcinoma from Inflammatory Mass in Chronic Calcific Pancreatitis
by: Thara Pratap, et al.
Published: (2024-01-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

An Autopsy Case of Anaplastic Pancreatic Ductal Carcinoma (Spindle Cell Type) Multiple Onset in the Pancreas
by: Hiroyuki Ito, et al.
Published: (2019-04-01)

Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
by: Jun Ushio, et al.
Published: (2021-03-01)

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
by: Jane E. Rogers, et al.
Published: (2020-08-01)

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
by: Marwa Elsayed, et al.
Published: (2021-04-01)

Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma
by: Gennaro Nappo, et al.
Published: (2023-03-01)

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
by: Chengru Yang, et al.
Published: (2024-01-01)

Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study
by: Naohiro Kato, et al.
Published: (2023-05-01)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01)

Circ_0001068 accelerates the development of ovarian cancer by promoting FXYD5 expression through inhibiting mir-149-5p activity
by: Zhengqian Mou, et al.
Published: (2024-11-01)

Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case–control study
by: Akinobu Koiwai, et al.
Published: (2023-06-01)

Identification of zebrafish FXYD11a protein that is highly expressed in ion-transporting epithelium of the gill and skin and its possible role in ion homeostasis
by: Kaori Saito, et al.
Published: (2010-08-01)

Effective Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced CT for Differentiating Autoimmune Pancreatitis from Pancreatic Ductal Adenocarcinoma
by: Akihiko Kanki, et al.
Published: (2025-07-01)

Clinical Features and Prognostic Impact of Pancreatic Ductal Adenocarcinoma without Dilatation of the Main Pancreatic Duct: A Single-Center Retrospective Analysis
by: Takuya Takayanagi, et al.
Published: (2023-03-01)

Targeting Advanced Pancreatic Ductal Adenocarcinoma: A Practical Overview
by: Chiara Citterio, et al.
Published: (2025-07-01)

Nomogram for Predicting Distant Metastasis of Pancreatic Ductal Adenocarcinoma: A SEER-Based Population Study
by: Weibo Li, et al.
Published: (2022-10-01)

CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic PancreatitisSummary
by: Supriya Srinivasan, et al.
Published: (2025-01-01)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
by: Shinichiro Yamada, et al.
Published: (2021-03-01)

Synchronous solid pseudopapillary neoplasm and invasive ductal carcinoma of the pancreas: a case report
by: Chikanori Tsutsumi, et al.
Published: (2020-08-01)

Survival benefit of adjuvant therapy completion with early initiation for patients with pancreatic ductal adenocarcinoma
by: Kenjiro Okada, et al.
Published: (2025-07-01)

Single vein resection in surgery for pancreatic ductal carcinoma as a criterion of resectability
by: D. A. Chichevatov, et al.
Published: (2022-09-01)

Botanical drugs and their natural compounds: a neglected treasury for inhibiting the carcinogenesis of pancreatic ductal adenocarcinoma
by: Yunfei Dai, et al.
Published: (2024-12-01)

Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia
by: D.-Y. Oh, et al.
Published: (2025-06-01)

Diagnostic Ability and Safety of Repeated Pancreatic Juice Cytology Using an Endoscopic Nasopancreatic Drainage Catheter for Pancreatic Ductal Adenocarcinoma: A Multicenter Prospective Study
by: Shinya Nakamura, et al.
Published: (2023-08-01)

Transcriptional Profile of Human Pancreatic Acinar Ductal Metaplasia
by: Jinmai Jiang, et al.
Published: (2023-01-01)

Novel Treatment Strategies for Advanced Pancreatic Ductal Adenocarcinoma
by: CHENG Yuejuan, et al.
Published: (2022-03-01)